newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders

ENGLEWOOD, Colo., Dec. 16, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today released the following letter to stockh